Sano Genetics: Funding, Investors & Team (Oct 2026)
Sano Genetics is a company in the health technology field that specializes in personalized medicine and genetics. Their main objective is to encourage individuals to provide their genetic and health information for research, with the aim of improving scientific knowledge and individualized healthcare solutions. Sano Genetics commonly works on genetic research initiatives, where participants can share their genetic data to support wider medical research efforts.
Sano Genetics has raised $26.3M across 5 funding rounds on record, the most recent an undisclosed round announced in Jul 2024.
Sano Genetics Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Sano Genetics Funding Rounds
1 of 5 rounds was announced without a disclosed amount and is excluded from the total.
Sano Genetics raised $3.4M in a Seed announced in Jan 2021.
1.2 years later, a Series A of $11.1M was announced in Mar 2022.
1.4 years later, an undisclosed round of $420k was announced in Aug 2023.
5 months later, a Series A of $11.4M was announced in Jan 2024.
6 months later, an undisclosed round was announced in Jul 2024 with no disclosed amount.
Sano Genetics Founders and Leadership Team
Contact details for the Sano Genetics team: 1 of 2 have an email address on file.
Start 14-day free trial →Sano Genetics Funding Compared to Other Biotechnology Startups
Funded Startups Like Sano Genetics in Biotechnology and Cambridge
Companies Similar to Sano Genetics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Sano Genetics Funding FAQs
What does Sano Genetics do?
Sano Genetics is a company in the health technology field that specializes in personalized medicine and genetics. Their main objective is to encourage individuals to provide their genetic and health information for research, with the aim of improving scientific knowledge and individualized healthcare solutions. Sano Genetics commonly works on genetic research initiatives, where participants can share their genetic data to support wider medical research efforts.
How much funding has Sano Genetics raised?
Sano Genetics has raised $26.3M across 5 rounds on record.
When did Sano Genetics last raise funding?
Sano Genetics' most recent funding round on record was announced in Jul 2024. The amount was not disclosed.
Who founded Sano Genetics?
FundedIQ lists William Jones (Founder) at Sano Genetics.
Who is the CEO of Sano Genetics?
Patrick Short is listed as CEO at Sano Genetics.
Where is Sano Genetics headquartered?
Sano Genetics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Sano Genetics have?
Sano Genetics is in the 11-50 employee band.
About FundedIQ's Sano Genetics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sano Genetics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.